Journal of Molecular Structure, Год журнала: 2024, Номер 1323, С. 140748 - 140748
Опубликована: Ноя. 16, 2024
Язык: Английский
Journal of Molecular Structure, Год журнала: 2024, Номер 1323, С. 140748 - 140748
Опубликована: Ноя. 16, 2024
Язык: Английский
International Journal of Biological Macromolecules, Год журнала: 2024, Номер 267, С. 131268 - 131268
Опубликована: Апрель 4, 2024
Язык: Английский
Процитировано
4Heliyon, Год журнала: 2024, Номер 10(17), С. e37196 - e37196
Опубликована: Авг. 31, 2024
Язык: Английский
Процитировано
4International Journal of Biological Macromolecules, Год журнала: 2025, Номер unknown, С. 141057 - 141057
Опубликована: Фев. 1, 2025
Язык: Английский
Процитировано
0Pharmacology Research & Perspectives, Год журнала: 2025, Номер 13(2)
Опубликована: Март 24, 2025
The research and design of new inhibitors for the treatment diseases such as Alzheimer's disease glaucoma through inhibition cholinesterases (ChEs; acetylcholinesterase, AChE butyrylcholinesterase, BChE) carbonic anhydrase enzymes are among important targets. Here, a series novel sulfonamide-bearing pyrazolone derivatives (1a-f 2a-f) were successfully synthesized characterized by using spectroscopic analytical methods. inhibitory activities these newly compounds evaluated both in vitro silico their effect on anhydrases (hCA I hCA II isoenzymes) ChEs. studies showed that demonstrated potential activity, with KI values covering following ranges: 18.03 ± 2.86-75.54 4.91 nM I, 24.84 1.57-85.42 6.60 II, 7.45 0.98-16.04 1.60 AChE, 34.78 5.88-135.70 17.39 BChE. Additionally, many promising some higher potency than reference compounds. While have also identified binding positions compounds, crystal structures BChE receptors. varying affinities designed ChEs isoenzymes show could hold promise alternative agents selectively inhibiting hCAs glaucoma.
Язык: Английский
Процитировано
0Biotechnology and Applied Biochemistry, Год журнала: 2025, Номер unknown
Опубликована: Апрель 1, 2025
Diabetes mellitus, especially type 2, is a global health challenge, and effective enzyme inhibitors are essential for its control. Conventional have drawbacks such as gastrointestinal side effects regional availability, examples being acarbose epalrestat. Moreover, tyrosinase, which controls melanin synthesis also target reducing hyperpigmentation disorders. In this study, we demonstrate the inhibitory action of novel isoindole-1,3-dione-based sulfonamides against key enzymes associated with diabetes hyperpigmentation, α-Glucosidase (α-Glu), aldose reductase (ALR2), tyrosinase. The presynthesized compounds (3, 4a-k) tested in vitro inhibition α-Glu, ALR2, tyrosinase compared reference acarbose, epalrestat, kojic acid. Kinetic studies showed that both competitive noncompetitive modes were observed. Among them, compound 4a displayed highest ALR2 potency (Ki: 0.211 µM) was superior to terms 4k shown be more potent Ki 0.049 µM, particularly versus acarbose. Compound 4d excellent activity 1.43 assays, much than Molecular docking revealed details enzyme-binding interactions, justify respective mechanisms Structure-activity relationships reflected strong hydrogen bonding hydrophobic interactions led higher potency. These findings highlight importance therapeutic agents will provide valuable leads developing multifunctional diabetic complications hyperpigmentation.
Язык: Английский
Процитировано
0Journal of Molecular Structure, Год журнала: 2025, Номер unknown, С. 142331 - 142331
Опубликована: Апрель 1, 2025
Язык: Английский
Процитировано
0Enzyme and Microbial Technology, Год журнала: 2025, Номер 189, С. 110657 - 110657
Опубликована: Апрель 17, 2025
Язык: Английский
Процитировано
0Biotechnology and Applied Biochemistry, Год журнала: 2024, Номер 71(5), С. 1079 - 1093
Опубликована: Май 7, 2024
The identification of novel acetylcholinesterase inhibitors holds significant relevance in the treatment Alzheimer's disease (AD), prevailing form dementia. exploration alternative to conventional is steadily gaining prominence. Quinones, categorized as plant metabolites, represent a specific class compounds. In this study, inhibitory effects various naphthoquinone derivatives, along with anthraquinone and its on (AChE) enzyme were investigated for purpose. An vitro investigation was conducted examine these compounds order clarify possible mechanism inhibition interaction between chemicals. addition, an silico carried out understand conceivable inhibitor binding process enzyme's active site. acquired outcomes corroborated results. AChE found be effectively inhibited by both naphthoquinones anthraquinones, constant (K
Язык: Английский
Процитировано
2Archiv der Pharmazie, Год журнала: 2023, Номер 357(2)
Опубликована: Ноя. 16, 2023
Abstract In this study, the mechanisms by which enzymes glucose‐6‐phosphate dehydrogenase (G6PD), 6‐phosphogluconate (6PGD), glutathione reductase (GR), glutathione‐S‐transferase (GST), and thioredoxin (TrxR) are inhibited methotrexate (MTX) were investigated, as well whether antioxidant morin can mitigate or prevent these adverse effects in vivo silico. For 10 days, rats received oral doses of (50 100 mg/kg body weight). On fifth day, a single intraperitoneal injection MTX (20 weight) was administered to generate toxicity. Decreased activities G6PD, 6PGD, GR, GST, TrxR associated with MTX‐related toxicity while treatment increased activity enzymes. The docking analysis indicated that H‐bonds, pi–pi stacking, pi–cation interactions dominant enzyme‐binding pockets. Furthermore, docked poses against GST subjected molecular dynamic simulations for 200 ns, assess stability both complexes also predict key amino acid residues binding pockets throughout simulation. results study suggest may be viable means alleviating enzyme important regulatory MTX‐induced
Язык: Английский
Процитировано
5Journal of Molecular Recognition, Год журнала: 2024, Номер 37(3)
Опубликована: Март 21, 2024
Abstract Glucose‐6‐phosphate dehydrogenase (G6PD) and 6‐phosphogluconate (6PGD) are pentose phosphate pathway enzymes. Compounds with a heterocyclic pyrrole ring system containing this atom can be derivatized various functional groups into highly effective bioactive agents. In study, derivatives on these enzyme's activity were investigated. The IC 50 values of different concentrations for G6PD found in the range 0.022–0.221 mM K i 0.021 ± 0.003–0.177 6PGD 0.020–0.147, 0.013 0.002–0.113 0.030 mM. 2‐acetyl‐1‐methylpyrrole ( 1g ) showed best inhibition value addition, silico molecular docking experiments performed to elucidate how 1a – g interact binding sites target study's findings could used create innovative therapeutics that treatment many diseases, especially cancer manifestations.
Язык: Английский
Процитировано
1